Correlation Between Acrivon Therapeutics, and Candel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Candel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Candel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Candel Therapeutics, you can compare the effects of market volatilities on Acrivon Therapeutics, and Candel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Candel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Candel Therapeutics.
Diversification Opportunities for Acrivon Therapeutics, and Candel Therapeutics
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Acrivon and Candel is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Candel Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Candel Therapeutics and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Candel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Candel Therapeutics has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Candel Therapeutics go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Candel Therapeutics
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to generate 0.78 times more return on investment than Candel Therapeutics. However, Acrivon Therapeutics, Common is 1.29 times less risky than Candel Therapeutics. It trades about -0.08 of its potential returns per unit of risk. Candel Therapeutics is currently generating about -0.1 per unit of risk. If you would invest 817.00 in Acrivon Therapeutics, Common on August 29, 2024 and sell it today you would lose (82.00) from holding Acrivon Therapeutics, Common or give up 10.04% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Candel Therapeutics
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Candel Therapeutics |
Acrivon Therapeutics, and Candel Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Candel Therapeutics
The main advantage of trading using opposite Acrivon Therapeutics, and Candel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Candel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Candel Therapeutics will offset losses from the drop in Candel Therapeutics' long position.| Acrivon Therapeutics, vs. Bright Minds Biosciences | Acrivon Therapeutics, vs. HP Inc | Acrivon Therapeutics, vs. Intel | Acrivon Therapeutics, vs. Chevron Corp |
| Candel Therapeutics vs. Aerovate Therapeutics | Candel Therapeutics vs. Adagene | Candel Therapeutics vs. Acrivon Therapeutics, Common | Candel Therapeutics vs. Rezolute |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |